文献速递生殖医学

miRNA-339-5p在多囊卵巢综合征患者血管内皮祖细胞功能中的作用

The role of miRNA-339-5p in the function of vascular endothelial progenitor cells in patients with PCOS.
PubMed 文献 · Reprod Biomed Online · 2021-10-03

研究收集76例对照和84例多囊卵巢综合征(PCOS)患者的临床数据,检测血清去甲肾上腺素、非对称性二甲基精氨酸(ADMA)、晚期糖基化终末产物(AGE)和沉默信息调节因子1(SIRT1),并比较转染miRNA-339-5p模拟物或抑制剂前后内皮祖细胞(EPC)功能及PI3K、AKT、SIRT1、PGC-1α表达。结果显示PCOS患者交感兴奋增加、EPC受损,miRNA-339-5p上调可通过抑制PI3K/AKT和SIRT1/PGC-1α信号通路抑制EPC功能。

要点

  • PCOS患者血清去甲肾上腺素、ADMA、AGE显著升高,SIRT1显著降低。
  • PCOS患者EPC迁移和成管能力显著下降,miRNA-339-5p表达显著升高。
  • miRNA-339-5p抑制剂组EPC功能最佳,模拟物组最弱。

核心结论

  • PCOS患者存在交感兴奋增加和EPC损伤,肥胖者更明显。
  • 上调的miRNA-339-5p可通过抑制PI3K/AKT和SIRT1/PGC-1α信号通路抑制EPC功能。

研究设计与样本

  • 收集76例对照和84例PCOS患者的临床数据。
  • 检测血清去甲肾上腺素、ADMA、AGE和SIRT1浓度。
  • 比较转染miRNA-339-5p模拟物或抑制剂前后EPC功能及PI3K、AKT、SIRT1、PGC-1α表达。

主要发现

  • PCOS患者血清去甲肾上腺素(P=0.009)、ADMA(P=0.044)、AGE(P<0.001)显著高于对照组,SIRT1显著低于对照组(P<0.001)。
  • 肥胖PCOS患者上述指标与对照组比较:去甲肾上腺素P=0.034、ADMA P=0.032、AGE P<0.001、SIRT1 P=0.023。
  • 与对照组相比,PCOS组EPC增殖略低但无显著差异,迁移(P=0.037)和成管(P=0.011)显著下降,miRNA-339-5p表达显著升高(P=0.035)。
  • PCOS组EPC中PI3K、AKT、SIRT1、PGC-1α mRNA(P=0.033、P=0.027、P=0.027、P=0.032)和蛋白(P=0.036、P=0.028、P=0.039、P=0.023)表达显著低于对照组。
  • 转染后PCOS患者EPC功能以miRNA-339-5p抑制剂组最佳、模拟物组最弱;抑制剂组PI3K、AKT、SIRT1蛋白表达较高(P<0.001、P=0.030、P=0.047),PGC-1α表达较低(P=0.003)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: miRNA-339 participates in diseases with endothelial progenitor cell (EPC) dysfunction. What is the role of miRNA-339-5p in EPC of polycystic ovary syndrome (PCOS)? DESIGN: Clinical data were collected from 76 controls and 84 PCOS patients. Noradrenaline, asymmetric dimethylarginine (ADMA), advanced glycation end products (AGE) and silent information regulator 1 (SIRT1) in the serum were measured. The functions of EPC and the expressions of PI3K, AKT, SIRT1 and PGC-1α in EPC before and after transfection with miRNA-339-5p mimic or miRNA-339-5p inhibitor were compared. RESULTS: Serum concentrations of noradrenaline, ADMA and AGE were significantly higher (P = 0.009, P = 0.044, P < 0.001) and the SIRT1 concentration was significantly lower (P < 0.001) in PCOS patients, especially obese ones (P = 0.034, P = 0.032, P < 0.001, P = 0.023) than in the control group. When compared with the controls, proliferation of the EPC was slightly lower (without a significant difference), the migration and tubular formation were significantly decreased (P = 0.037, P = 0.011), the expression of miRNA-339-5p in EPC was significantly higher (P = 0.035) and the expressions of PI3K, AKT, SIRT1 and PGC-1α were significantly lower in the PCOS group (mRNA: P = 0.033, P = 0.027, P = 0.027, P = 0.032; protein: P = 0.036, P = 0.028, P = 0.039, P = 0.023). After transfection, the functions of EPC from PCOS patients were best in the miRNA-339-5p inhibitor group, and weakest in the miRNA-339-5p mimic group. The miRNA-339-5p inhibitor group had higher protein expressions of PI3K, AKT and SIRT1 but lower expression of PGC-1α in PCOS patients (P < 0.001, P = 0.030, P = 0.047, P = 0.003). Similar results were obtained from the controls after transfection. CONCLUSION: Increased sympathetic excitation and damage to EPC were observed in PCOS patients, especially obese ones. Up-regulated miRNA-339-5p could inhibit the function of EPC by inhibiting the PI3K/AKT and SIRT1/PGC-1α signalling pathways.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zhang J, Xu W, Li S, et al. The role of miRNA-339-5p in the function of vascular endothelial progenitor cells in patients with PCOS. Reprod Biomed Online. 2021. PMID: 35151575. doi:10.1016/j.rbmo.2021.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。